Source: Health Canada shortage reports · Updated Jul 22, 2026
Some Irbesartan products are in shortage in Canada (10 of 43 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An angiotensin receptor blocker used to lower high blood pressure.
Products affected
10 / 43
In shortage since
Sep 17, 2018
Reports on file
161
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP-IRBESARTAN
75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418193 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
150MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418207 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
150MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418207 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418215 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418193 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418215 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
BIO-IRBESARTAN
300MG · TABLET · BIOMED PHARMA
DIN 02446162 · since Mar 12, 2019, no end estimate · Delay in shipping of the drug.
Active shortage
BIO-IRBESARTAN
150MG · TABLET · BIOMED PHARMA
DIN 02446154 · since Mar 10, 2019, no end estimate · Delay in shipping of the drug.
Active shortage
BIO-IRBESARTAN
75MG · TABLET · BIOMED PHARMA
DIN 02446146 · since Sep 17, 2018, no end estimate · Demand increase for the drug.
Active shortage
APO-IRBESARTAN
75MG · TABLET · APOTEX INC
DIN 02386968 · since Nov 5, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
AURO-IRBESARTAN
75MG · TABLET · AURO PHARMA INC
DIN 02406098 · since Oct 17, 2018, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
AURO-IRBESARTAN
150MG · TABLET · AURO PHARMA INC
DIN 02406101 · since Oct 17, 2018, no end estimate · Requirements related to complying with good manufacturing practices.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Irbesartan is currently affected by 10 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, BIOMED PHARMA, APOTEX INC, AURO PHARMA INC.
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug; demand increase for the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Irbesartan is classified under “ANGIOTENSIN II ANTAGONISTS, PLAIN” (ATC C09CA).
Recent changes
Jul 22, 2026
New report filed
Common questions
What is Irbesartan used for?
An angiotensin receptor blocker used to lower high blood pressure.
When will Irbesartan be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Irbesartan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.